Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 1313 to 1362 of 8289 in total
Value Type: Measured
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
657\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
rgs19-interacting protein 1 (gaip c-terminus interacting protein gipc) (rgs-gaip interacting protein) (tax interaction protein 2) (tip-2). [source:swissprot;acc:o14908]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6079.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6824.47\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12258\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 12 (potassium/chloride transporters), member 9; cation-chloride cotransporter-interacting protein. [source:refseq;acc:nm\_020246]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8537.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8913.52\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04406\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
658\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
apical-like protein (apxl protein). [source:swissprot;acc:q13796]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6088.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6834.87\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12254\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
phosphatidylinositol-4-phosphate 5-kinase, type i, gamma; phosphatidylinositol-4-phosphate 5-kinase i-gamma; diphosphoinositide kinase; type i pip kinase; ptdins(4)p-5-kinase. [source:refseq;acc:nm\_012398]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
8720.22\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
9103.98\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.04401\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
659\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphatidylinositol-4-phosphate 5-kinase, type i, alpha. [source:refseq;acc:nm\_003557]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
shroom-related protein; f-actin-binding protein; likely ortholog of mouse shroom. [source:refseq;acc:nm\_020859]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6089.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6835.34\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12253\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
660\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
tyrosine-protein kinase abl2 (ec 2.7.1.112) (tyrosine kinase arg). [source:swissprot;acc:p42684]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8155.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8513.92\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04398\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
u2 small nuclear ribonucleoprotein auxiliary factor 35 kda subunit related-protein 1. [source:swissprot;acc:q15695]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5575.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6254.85\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12191\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
661\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase src (ec 2.7.1.112) (p60-src) (c-src). [source:swissprot;acc:p12931]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8155.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8513.91\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04398\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
step ii splicing factor slu7. [source:refseq;acc:nm\_006425]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5575.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6254.85\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12191\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
662\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
partitioning defective-6 homolog gamma (par-6 gamma) (par6d). [source:swissprot;acc:q9byg4]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6374.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7145.59\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12094\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tyrosine-protein kinase hck (ec 2.7.1.112) (p59-hck/p60-hck) (hemopoietic cell kinase). [source:swissprot;acc:p08631]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8155.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8513.91\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.04398\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
663\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase abl1 (ec 2.7.1.112) (p150) (c-abl). [source:swissprot;acc:p00519]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8155.28\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8513.92\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tubby protein homolog. [source:swissprot;acc:p50607]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6374.65\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
7145.59\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.12094\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
664\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein kinase c, iota type (ec 2.7.1.37) (npkc-iota) (atypical protein kinase c-lamda/iota) (apkc-lambda/iota). [source:swissprot;acc:p41743]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase fyn (ec 2.7.1.112) (p59-fyn) (syn) (slk). [source:swissprot;acc:p06241]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8155.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8513.91\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04398\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
665\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
numb protein homolog (h-numb) (protein s171). [source:swissprot;acc:p49757]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6374.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7145.59\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12094\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase fgr (ec 2.7.1.112) (p55-fgr) (c-fgr). [source:swissprot;acc:p09769]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8155.25\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8513.91\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04398\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
666\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
grb2-related adaptor protein 2 (gads protein) (growth factor receptor binding protein) (grblg) (grf40 adaptor protein) (grf-40) (grb-2-like protein) (grb2l) (grbx) (p38) (hematopoietic cell-associated adaptor protein grpl) (adapter protein grid) (sh3-sh2-sh3 adaptor mona). [source:swissprot;acc:o75791]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8155.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8514.01\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04395\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tbc1 domain family member 5. [source:swissprot;acc:q92609]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6374.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7145.59\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12094\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
667\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(t) beta subunit 3 (transducin beta chain 3). [source:swissprot;acc:p16520]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7930.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8278.46\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04391\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tubby related protein 1 (tubby-like protein 1). [source:swissprot;acc:o00294]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6374.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7145.59\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12094\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
668\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nadp-dependent leukotriene b4 12-hydroxydehydrogenase (ec 1.1.1.-). [source:swissprot;acc:q14914]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8722.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9105.25\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04384\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar protein sorting 29 (vesicle protein sorting 29) (hvps29) (mds007) (pep11) (dc7/dc15). [source:swissprot;acc:q9ubq0]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6374.65\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
7145.59\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.12094\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
669\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
numb-like protein (numb-r). [source:swissprot;acc:q9y6r0]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
peroxisomal n1-acetyl-spermine/spermidine oxidase. [source:refseq;acc:nm\_152911]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8843.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9230.12\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04377\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
670\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuron navigator 2 isoform l; retinoic acid inducible in neuroblastoma; pore membrane and/or filament interacting like protein 2; helicase helad1. [source:refseq;acc:nm\_145117]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7887.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8232.61\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0437\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tubby related protein 3 (tubby-like protein 3). [source:swissprot;acc:o75386]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6374.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7145.59\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12094\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
671\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
potassium voltage-gated channel subfamily a member 2 (potassium channel kv1.2) (rbk2) (hbk5) (ngk1) (mk2) (hukiv). [source:swissprot;acc:p16389]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7812.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8154.08\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04367\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar protein sorting 35 (vesicle protein sorting 35) (hvps35) (maternal-embryonic 3). [source:swissprot;acc:q96qk1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6374.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7145.59\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12094\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
672\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
c18b11 homolog (44.9kd). [source:refseq;acc:nm\_152260]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7957.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8304.58\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04364\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein kinase c, zeta type (ec 2.7.1.37) (npkc-zeta). [source:swissprot;acc:q05513]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6374.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7145.59\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12094\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
673\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor btf3 (rna polymerase b transcription factor 3). [source:swissprot;acc:p20290]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6933.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7766.54\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1202\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
z-protein (protein cgi-119) (s1r protein). [source:swissprot;acc:q9hc24]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7957.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8304.58\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.04364\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
674\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homer, neuronal immediate early gene, 3. [source:refseq;acc:nm\_004838]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7228.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7543.86\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sprouty homolog 4 (spry-4). [source:swissprot;acc:q9c004]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5549.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6215.42\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12006\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
675\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuron navigator 1; neuron navigator-1; pore membrane and/or filament interacting like protein 3. [source:refseq;acc:nm\_020443]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7886.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8230.98\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04363\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sprouty homolog 3 (spry-3). [source:swissprot;acc:o43610]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5549.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6215.42\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12006\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
676\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuron navigator 3; pore membrane and/or filament interacting like protein 1; steerin 3. [source:refseq;acc:nm\_014903]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7886.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8231.03\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04363\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sprouty homolog 1 (spry-1) (fragment). [source:swissprot;acc:o43609]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5549.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6215.42\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12006\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
677\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
potassium voltage-gated channel subfamily a member 1 (potassium channel kv1.1) (huki) (hbk1). [source:swissprot;acc:q09470]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7811.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8152.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04361\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sprouty homolog 2 (spry-2). [source:swissprot;acc:o43597]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5549.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6215.42\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12006\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
678\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homer, neuronal immediate early gene, 1b. [source:refseq;acc:nm\_004272]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7228.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7543.66\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0436\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor btf3 homolog 3. [source:swissprot;acc:q13892]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6938.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7770.65\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11998\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
679\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adenylosuccinate synthase-like 1. [source:refseq;acc:nm\_152328]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6503.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7282.94\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11992\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
contactin 2 precursor (axonin-1) (axonal glycoprotein tag-1) (transient axonal glycoprotein 1) (tax-1). [source:swissprot;acc:q02246]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8154.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8509.76\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04359\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
680\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adenylosuccinate synthetase (ec 6.3.4.4) (imp--aspartate ligase) (adss) (ampsase). [source:swissprot;acc:p30520]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6503.03\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7282.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11986\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
contactin 5 isoform long; neural adhesion molecule. [source:refseq;acc:nm\_014361]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
8154.34\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
8509.76\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.04359\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
681\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
contactin 6; neural adhesion molecule. [source:refseq;acc:nm\_014461]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ribosomal protein l24-like; 60s ribosomal protein l30 isolog; my024 protein; homolog of yeast ribosomal like protein 24. [source:refseq;acc:nm\_016304]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7170.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8029.64\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11976\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/